NIFTY
6.10  0.06%
 11053.90
S&P BSE SENSEX
52.16  0.14%
 37402.49
Dr. Reddys Laboratories Ltd.
NSE : DRREDDY BSE : 500124 ISIN code : INE089A01023
on 19-Aug-2019
NSE
16.55    0.66%
Rs. 2509.10
 
Days Low
Rs. 2503
Days High
Rs. 2567.5

Open Rs. 2525
 
52 week Low
Rs. 2065.3
52 week High
Rs.2965.2
 
 
Bid :                 2510.50 (5)
Offer :        0.00 (0)
BSE
Rs.2510.50
17.7    0.71%
on 19-Aug-2019
BSE
17.7    0.71%
Rs. 2510.50
 
Days Low
Rs. 2495
Days High
Rs. 2568.95

Open Rs. 2540
 
52 week Low
Rs. 1872.95
52 week High
Rs.2964
 
 
Bid :                 2510.50 (5)
Offer :        0.00 (0)
NSE
Rs.2509.10
16.55    0.66%
 
 
Last Price (Rs.)  2510.50 Value  51499499.00
Net Change (Rs.)  17.70 Best Buy  2510.50
Volume  20292 Best Sell  0.00
Prev.Close (Rs.)  2492.80 Best Quantity  5
Open (Rs.)  2525.00 Sell Quantity  0
High (Rs.)  2567.50 52-Week High (Rs.)  2965.20
Low (Rs.)  2503.00 52-Week Low (Rs.)  2065.30
Face Value (Rs.)  5 Market Cap.(Rs/ Mn)  417028.80
 
BSE
You need to upgrade your Flash Player
 
Financial (Rs .in Million)
Balance Sheet
Share Capital830.00 830.00 829.00 
Share Capital830.00 830.00 829.00 
Share Capital830.00 830.00 829.00 
Share Capital830.00 830.00 829.00 
Share Capital830.00 830.00 829.00 
Currents Investments21144.00 16828.00 12991.00 
More> 
 
Top 5 PeerCompanies * (Rs .in Million)
Company NameLTP* M.CapBVP/EDiv.Yield
Sun Pharma Inds. 425.80 1021637 98.39 125.11 0.65
Divis Lab 1517.75 402915 272.75 30.23 1.05
Cipla 475.90 383522 203.91 20.30 0.63
Ranbaxy Labs. 859.90 366028 1.53 0.00 0.00
Piramal Enterprises 1797.40 357407 1174.23 0.00 1.56
 
Mutual Funds Holdings
 
Quarterly Result
(Rs .in millions)Jun 2019Mar 2019Dec 2018
Net Sales25087.0026452.0027317.00
Operating Profit9021.005093.007797.00
PBDT8900.005006.007639.00
Net Profit5481.002028.003994.00
More> 
 
Company News
8/19/2019 12:00:00 AM
Dr. Reddy’s Lab launches Versavo in India
8/19/2019 12:00:00 AM
Dr. Reddy’s Lab advances on launching Versavo in India
8/16/2019 12:00:00 AM
Dr. Reddy’s Lab get CRL from USFDA for NuvaRing, Copaxone
More>
 
Ratios
   Earnings Per Share (Rs)76.95 
   Book NAV/Share(Rs)759.31 
   PAT Margin (%)12.02 
   Asset Turnover(x)0.64 
   PER(x)36.05 
   Yield(%)0.72 
   EV/Core EBITDA(x)18.52 
   M Cap / Sales4.33 
   Net Sales Growth(%)13.53 
   PAT Growth(%)125.31 
   Total Debt/Equity(x)0.08 
   Current Ratio(x)2.90 
   Quick Ratio(x)2.25 
   Total Debt/Mcap(x)0.02 
More>